The current CRMD market cap is 487.83M. The company's latest EPS is USD -0.8454 and P/E is -6.41.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 7k | 29k | 0 | 0 | 0 |
Operating Income | -6.96M | -8.39M | -11.02M | -11.81M | -10.47M |
Net Income | -6.85M | -8.21M | -10.57M | -11.27M | -9.74M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 283k | 239k | 191k | 65k | 0 |
Operating Income | -21.01M | -27.22M | -29.44M | -30.62M | -48.96M |
Net Income | -16.43M | -22.03M | -28.21M | -29.7M | -46.34M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 62.08M | 62.04M | 59.23M | 57.03M | 91.43M |
Total Liabilities | 5.77M | 6.98M | 5.31M | 7.98M | 8.23M |
Total Equity | 56.31M | 55.06M | 53.93M | 49.05M | 83.2M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 29.48M | 49.31M | 68.95M | 62.04M | 82.06M |
Total Liabilities | 5.83M | 5.09M | 6.15M | 6.98M | 11.92M |
Total Equity | 23.65M | 44.22M | 62.8M | 55.06M | 70.14M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -18.2M | -24.36M | -10.39M | -18.97M | -27.66M |
Investing | -3.71M | -3.71M | -14.69M | -17.07M | -17.66M |
Financing | 11.85M | 17.9M | 7.2M | 12.55M | 55.45M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -15.05M | -21.97M | -21.16M | -24.36M | -38.41M |
Investing | -12.02M | 7.43M | -9.14M | -3.71M | -17.06M |
Financing | 25.8M | 40.1M | 41.76M | 17.9M | 55.92M |
Market Cap | 487.83M |
Price to Earnings Ratio | -6.41 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 6.81 |
Price to Book Ratio | 4.24 |
Dividend Yield | - |
Shares Outstanding | 54.81M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0.09 (0.97%) |
Company Name | CorMedix Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.cormedix.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.